Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2012 10:30 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Initiates Phase 1 Clinical Study of MM-141 in Patients With Advanced Solid Tumors

CAMBRIDGE, Mass., Dec. 12, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced enrollment of its first patient in a Phase 1 clinical study of a novel compound for...
December 05, 2012 10:59 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President & CEO, is scheduled to present at the 31st Annual...
December 03, 2012 12:52 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference

CAMBRIDGE, Mass., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, CFO, is scheduled to present at the Oppenheimer 23rd Annual...
November 19, 2012 13:37 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present at the J.P. Morgan SMid Cap Conference

CAMBRIDGE, Mass., Nov. 19, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President & CEO, is scheduled to present at the J.P. Morgan...
November 14, 2012 08:00 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Reports Third Quarter 2012 Financial Results

Five Novel Therapeutic Candidates Progressing Through Clinical Development, Including One Phase 3 Trial in Second Line Pancreatic Cancer and Four Phase 2 Trials in Multiple Cancer...
November 06, 2012 11:34 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present at Lazard Capital Markets' 9th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, Chief Financial Officer, is scheduled to present at the Lazard...
November 05, 2012 08:00 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Announces Timing of Third Quarter 2012 Investor Conference Call

CAMBRIDGE, Mass., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that the company will host its Third Quarter 2012 Investor Conference Call and webcast...
October 31, 2012 16:00 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present Preclinical Data at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

CAMBRIDGE, Mass., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) announced today that preclinical data on two novel cancer compounds will be presented at the 24th...
September 12, 2012 09:56 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present at the UBS Global Life Sciences Conference

CAMBRIDGE, Mass., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, Chief Financial Officer, is scheduled to present at the UBS...
September 07, 2012 11:57 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 7, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President and Chief Executive Officer, is scheduled to present at...